Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Biocept Inc

(NASDAQ: BIOC)
Add to Portfolio
unch (unch)
as of 13:34 EST

Last 0.33
Change unch (unch)
Open 0.34
Prev. Close 0.33
Today's Range
0.32
0.34
52wk Range
0.23
2.11
Volume 2,213,808
Avg Volume 3,127,425
Sector All Sectors By Industry

Perfomance Comparison

Name Today 3-Month 1-Year
BIOC unch -33.98% -66.46%
DJIA +0.49% +6.16% +13.49%
S&P 500 +0.59% +8.76% +21.97%

Key Statistics

Annual EPS -2.67
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 15,430
Weighted Alpha -62.10
Standard Deviation +0.13
Profit Margin 3.63%
Beta 1.52

Growth Rates

YTD +18.46%
1-Year -66.27%
3-Year -99.45%
5-Year -99.88%

Opinion

Sell Hold Buy

Recent Headlines

Biocept Appoints Cory J. Dunn Senior Vice President of

PR Newswire via COMTEX - Fri Feb 14, 08:05AM EST
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces the prom(full story)
BIOC: 0.33 (unch)

Biocept Enters into Laboratory Services Agreement with

PR Newswire via COMTEX - Mon Feb 10, 08:05AM EST
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it (full story)
BIOC: 0.33 (unch)

Biocept to Present at the 22nd Annual BIO CEO &

PR Newswire via COMTEX - Tue Feb 04, 08:05AM EST
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that Pre(full story)
BIOC: 0.33 (unch)

Biocept Announces Validation and Availability of its

PR Newswire via COMTEX - Tue Jan 14, 08:05AM EST
Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that its(full story)
BIOC: 0.33 (unch)

Biocept, Inc. Awarded United States Patent for the Use

PR Newswire via COMTEX - Wed Jan 08, 09:00AM EST
Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular offerings designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it (full story)
BIOC: 0.33 (unch)